Risk-Based Determination of Analytical Sensitivity (LOQ) for Nitrosamine Impurities Using Acceptable Intake Limits
N-nitrosamine impurities found in the global pharmaceutical supply chain have forced an urgent transformation in the development of risk-based analytical monitoring and advanced quality control standards. The pivotal 2018 finding of the compound N-nitrosodimethylamine in the "sartan" drug class prompted the transition...